ArriVent BioPharma, Inc.
Ownership
Ownership Structure
Who owns ArriVent BioPharma, Inc. (AVBP)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 60.1% of the shares are freely tradable; institutional investors hold 95.9%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 9.16 | 4,515,531 | +2.6 | 06/30/2026 |
| Hillhouse Capital Advisors, Ltd. | 7.97 | 3,929,117 | +0.0 | 06/30/2026 |
| BlackRock Inc | 6.59 | 3,250,396 | +28.5 | 06/30/2026 |
| Orbimed Advisors LLC | 6.14 | 3,027,328 | +0.0 | 06/30/2026 |
| FMR Inc | 5.64 | 2,778,959 | -7.9 | 06/30/2026 |
| Octagon Capital Advisors LP | 4.00 | 1,971,054 | +0.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.60 | 1,774,873 | +16.1 | 06/30/2026 |
| Sofinnova Ventures | 3.44 | 1,696,752 | +0.0 | 06/30/2026 |
| State Street Corp | 3.43 | 1,692,986 | +19.1 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| HBM Healthcare Investments AG Ord | 5.17 | 2,548,185 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| LaChapelle Robin | Chief Operating Officer | 176,429 | 2,381,792 $ | Oct 30, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | LaChapelle Robin | Chief Operating Officer | Other | 17,648 | 6.24 | 110,055 |
| Oct 30, 2026 | LaChapelle Robin | Chief Operating Officer | Other | 1,820 | 2.28 | 4,152 |
| Oct 30, 2026 | LaChapelle Robin | Chief Operating Officer | Other | 4,550 | 2.28 | 10,381 |
| Oct 30, 2026 | LaChapelle Robin | Chief Operating Officer | Other | 410 | 2.28 | 935 |
| Oct 30, 2026 | LaChapelle Robin | Chief Operating Officer | Other | 16,265 | 3.65 | 59,374 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.